Black African-American patients with primary myelofibrosis: a comparative analysis of phenotype and survival
Blood Adv
.
2023 Jun 27;7(12):2694-2698.
doi: 10.1182/bloodadvances.2022009611.
Authors
Naseema Gangat
1
,
Andrew Kuykendall
2
,
Najla Al Ali
2
,
Swati Goel
3
,
Maymona Abdelmagid
1
,
Aref Al-Kali
1
,
Hassan B Alkhateeb
1
,
Kebede H Begna
1
,
Abhishek Mangaonkar
1
,
Mark R Litzow
1
,
William Hogan
1
,
Mithun Shah
1
,
Mrinal M Patnaik
1
,
Animesh Pardanani
1
,
Rami Komrokji
2
,
Ayalew Tefferi
1
Affiliations
1
Division of Hematology, Mayo Clinic, Rochester, MN.
2
Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL.
3
Department of Oncology (Hematology), Montefiore Medical Center, Bronx, NY.
PMID:
36780345
PMCID:
PMC10333736
DOI:
10.1182/bloodadvances.2022009611
No abstract available
MeSH terms
Black or African American
Humans
Phenotype
Primary Myelofibrosis* / genetics